Palliative pylorus-preserving pancreatic head resection and postoperative chemotherapy versus primary chemotherapy alone for patients with advanced carcinoma of the pancreatic head
Completed
- Conditions
- Pancreatic head carcinomaCancer
- Registration Number
- ISRCTN20060588
- Lead Sponsor
- Humboldt University Berlin (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Medical centres experienced in surgical and medical care of patients with pancreatic head carcinoma.
Exclusion Criteria
No exclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival, measured after 3, 6 and 12 months
- Secondary Outcome Measures
Name Time Method 1. Quality of life, measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer patients (EORTC QLQ-C30) and the EORTC Quality of Life Questionnaire for Pancreatic cancer (QLQ PAN26). This will be measured after 3, 6 and 12 months<br>2. Surgical complications, measured after 3, 6 and 12 months<br>3. Toxicity of chemotherapy, measured after 3, 6 and 12 months